Group 1 - Weiteou signed a strategic cooperation agreement with Qiteng Robotics to focus on safety upgrades in high-risk industries, leveraging new materials and robotics [1] - Dongfang Caifu's subsidiary received approval from the CSRC to issue subordinate bonds totaling up to 20 billion yuan [2] - Haibo Zhongke's controlling shareholder plans to reduce holdings by up to 2.98% of the company's shares [3] Group 2 - Shengyang Technology's subsidiary FTA is expanding into the foreign satellite internet terminal business, which is still in the early commercialization stage [4] - Cangge Mining expects a net profit increase of 43.41%-53.1% for 2025, projecting a profit of 3.7-3.95 billion yuan [5] - Jinlongyu plans to invest approximately 1.2 billion yuan to build a production line for solid-state batteries with an annual capacity of 2 GWh [6] Group 3 - Shengda Resources intends to acquire a 55% stake in Guangxi Laibin Jinshi Mining for 269.5 million yuan [7] - Zhifei Biological's CA111 injection has entered Phase I clinical trials, targeting diabetes and weight loss treatment [8] - Qusleep Technology's specific shareholders plan to reduce their holdings by up to 2.58% of the company's shares [9] Group 4 - Innovation Medical's subsidiary has a product expected to generate revenue of 114,000 yuan in 2025 [11] - Blue Ocean Cursor noted that AI-driven revenue currently constitutes a small portion of overall revenue [12] - *ST Yanshi anticipates a loss for the 2025 fiscal year, with revenue expected to be below 300 million yuan [13] Group 5 - ST Yishite will lift risk warnings and change its stock name, resuming trading on January 14 [14] - Shaoyang Hydraulic clarified that its products do not directly serve commercial aerospace clients [15] - Boss Electric plans to invest 100 million yuan in Youte Smart Kitchen to deepen strategic cooperation [16] Group 6 - Guo An Da's controlling shareholder plans to reduce holdings by up to 3% of the company's shares [17] - *ST Mingjia has lifted the delisting risk warning following the completion of its restructuring plan [18] - Haixiang Pharmaceutical signed an innovative drug cooperation agreement with Wanbangde Pharmaceutical [19] Group 7 - Palm Holdings plans to transfer stakes in two project companies for debt compensation, amounting to 258 million yuan [20] - Bohai Leasing's subsidiary Avolon is projected to have a fleet of 1,132 aircraft by the end of 2025 [21] - Zhenyou Technology reported that satellite internet revenue accounted for approximately 7.15% of total revenue in the first three quarters of 2025 [22] Group 8 - Blue Arrow Electronics intends to acquire at least 51% of Chengdu Xinyi Technology [23] - Shunhao Co. stated that its investment in Tianshu Chuangxin will have a minimal impact on its 2025 performance [24][25] - Baichuan Co.'s deputy general manager plans to reduce holdings by up to 0.65% of the company's shares [26] Group 9 - Zhewen Interconnect reported that its GEO business has not yet formed a mature profit model [27] - XW Communication's controlling shareholder plans to reduce holdings by up to 1% of the company's shares [28] - Electric Science Digital indicated that its satellite communication products are not its main business [29] Group 10 - Bojun Technology expects a net profit increase of 35%-65% for 2025, projecting a profit of 828-1,012 million yuan [30] - Rongchang Bio signed a licensing agreement for the RC148 drug with AbbVie, with an initial payment of 650 million USD [31] - Guoxin Technology's state investment fund plans to reduce holdings by up to 2.37% of the company's shares [32] Group 11 - Hengxuan Technology's controlling shareholder plans to reduce holdings by up to 3% of the company's shares [33][34] - *ST Chengchang announced a stock suspension for investigation due to abnormal trading [35] - Zhongji Xuchuang's subsidiary plans to issue warrants to incentivize its core team [36] Group 12 - Zhuoshengwei expects a net loss of 255-295 million yuan for 2025 [37] - Pingtan Development anticipates a loss for the 2025 fiscal year [38] - Nanjing Bank's major shareholder increased its stake by 123.472 million shares [39] Group 13 - Jingao Technology expects a net loss of 4.5-4.8 billion yuan for 2025 [40] - Mingyang Smart plans to acquire control of Dehua Company, with stock suspension [41] - Vanadium Titanium Co. anticipates a loss for the 2025 fiscal year [42][43] Group 14 - Tianzhihang announced a delay in its "Smart Medical Center Construction Project" [44]

Group 1: Company News - *ST Chengchang announced a stock suspension for investigation after experiencing significant trading fluctuations, with a stock price increase of 162.65% since December 5, 2025, and 19 trading days of price limits within 25 days [7] - Debang Lighting plans to acquire 60.9171 million shares of Jiali Co. and subscribe to 100 million new shares, resulting in a 67.48% ownership stake in Jiali, marking a significant asset restructuring [7][8] - Mingyang Smart Energy is planning to acquire control of Zhongshan Dehua Chip Technology Co. through a combination of cash and stock issuance, with the transaction still in the planning stage [10] - Zhi Te New Materials announced a stock suspension for investigation after a 198.57% increase over six trading days [6] - Blue Arrow Electronics is planning to acquire at least 51% of Chengdu Xinyi Technology Co. in a cash transaction, which is still in the planning stage [10] Group 2: Industry News - The National Development and Reform Commission has issued guidelines to enhance the planning and investment direction of government investment funds, aiming to support the construction of a modern industrial system [2] - The Shanghai Gold Exchange has warned members to monitor market fluctuations in precious metals due to increased volatility and uncertainty [4] - The 2026 New Year commemorative coin and banknote reservation will be available from January 13 to January 14, 2026, through designated banks [2][3]

Group 1 - Blue Arrow Electronics plans to acquire at least 51% of Chengdu Xinyi Technology through cash, aiming for control without constituting a related party transaction or major asset restructuring [2] - Rongchang Biopharmaceutical has signed an exclusive licensing agreement with AbbVie for RC148, potentially receiving up to $4.95 billion in milestone payments, enhancing its global development and brand value [3] - Zhejiang Wen Interconnect's GEO business has not yet formed a mature profit model and currently has no revenue, despite being classified as a GEO concept stock [4] Group 2 - Mingyang Smart Energy is planning to acquire control of Dehua Company through a combination of share issuance and cash payment, with the stock set to be suspended for up to 10 trading days [5] - Ligong Navigation's commercial aerospace applications are still in the early stages of business layout, with revenue of approximately 154,400 yuan for the first three quarters of 2025 [6] - Haixiang Pharmaceutical has signed a cooperation agreement with Wanbangde Pharmaceutical to develop treatments for ALS, with an investment of 150 million yuan and a 15% revenue share from commercialization [7] Group 3 - ST Chengchang's stock has experienced significant trading anomalies, leading to a suspension for investigation due to four instances of abnormal trading within ten days [8] - Zhitex New Materials' stock has been suspended for investigation after six consecutive days of trading limits, with a total increase of 198.57% [9] - Zhongheng Design has won several design projects in the commercial aerospace sector, but the contract amounts are small, with related project revenue accounting for only 0.39% of total revenue [10] Group 4 - Dongfang Fortune's subsidiary has been approved to publicly issue subordinate bonds totaling up to 20 billion yuan [11] - Blue Focus's AI-driven revenue currently constitutes a small portion of overall revenue, with significant short-term price fluctuations observed [12] - ST Yishite's stock will be renamed and will no longer carry risk warnings, with trading resuming on January 14 [13] Group 5 - Jianghua Microelectronics is planning a change in control, leading to a stock suspension for up to two trading days [15] - Guoke Military Industry is collaborating with commercial aerospace companies on a rocket project that is still in the R&D phase, with minimal impact on main business revenue [16] - Gravity Media's GEO business has not yet formed a mature commercial model, with no related revenue generated [17] Group 6 - Shanghai Electric plans to invest $300 million in a high-density optoelectronic integrated circuit board project, expecting to generate 2 billion yuan in annual revenue upon full production [22] - Zhangge Mining expects a net profit of 3.7 billion to 3.95 billion yuan for 2025, representing a growth of 43.41% to 53.10% year-on-year [33] - Yonghui Supermarket anticipates a net loss for 2025 due to ongoing market challenges [34] Group 7 - National Integrated Circuit Industry Investment Fund plans to reduce its stake in Guoxin Technology by up to 2.37% [41] - Saifen Technology's shareholders plan to collectively reduce their stake by up to 6% [42] - Junda Shares' controlling shareholder plans to reduce its stake by up to 3% [43] Group 8 - Tengda Construction has won a municipal road project worth 56.1645 million yuan [48] - Lidong Group's subsidiary has received a notification for an aluminum alloy wheel project worth approximately 820 million yuan [49] - Tieke Railway has won a bid for a high-speed railway fastening project worth 511 million yuan [50]

公告显示，股票简称由"ST易事特"变更为"易事特"，证券代码仍为"300376"，撤销其他风险警示后，公 司股票交易的日涨跌幅限制不变，仍为20%。 北京商报讯（记者 马换换 李佳雪）1月12日晚间，ST易事特（300376）披露公告称，公司股票交易将 于1月13日停牌一天，自1月14日起撤销其他风险警示。 ...

人民财讯1月12日电，ST易事特（300376）1月12日公告，公司股票交易将于1月13日停牌一天，1月14 日开市起复牌并撤销其他风险警示，股票简称由"ST易事特"变更为"易事特"，公司股票交易的日涨跌幅 限制不变，仍为20%。 ...

格隆汇1月12日丨ST易事特（维权）(300376.SZ)公布，公司撤销其他风险警示的申请已获得深交所审核 同意。根据《创业板股票上市规则》的相关规定，公司股票交易将于2026年1月13日停牌一天，2026年1 月14日开市起复牌并撤销其他风险警示，证券简称将由"ST易事特"变更为"易事特"，证券代码仍 为"300376"，撤销其他风险警示后，公司股票交易的日涨跌幅限制不变，仍为20%。 ...

每经头条（nbdtoutiao）——年产量是传统大田120倍以上，1个人管理1栋楼！实探中国"植物工厂"：水 稻生产期从120天减到60天，没有虫害不用打农药 （记者 王晓波） 每经AI快讯，ST易事特1月12日晚间发布公告称，公司股票交易将于2026年1月13日停牌一天，2026年1 月14日开市起复牌并撤销其他风险警示，证券简称将由"ST易事特"变更为"易事特"，证券代码仍 为"300376"，撤销其他风险警示后，公司股票交易的日涨跌幅限制不变，仍为20%。 ...

格隆汇1月12日丨ST易事特(300376.SZ)公布，公司撤销其他风险警示的申请已获得深交所审核同意。根 据《创业板股票上市规则》的相关规定，公司股票交易将于2026年1月13日停牌一天，2026年1月14日开 市起复牌并撤销其他风险警示，证券简称将由"ST易事特"变更为"易事特"，证券代码仍为"300376"，撤 销其他风险警示后，公司股票交易的日涨跌幅限制不变，仍为20%。 ...

证券代码：300376 证券简称：ST 易事特 公告编号：2026-001 2、公司股票自 2026 年 1 月 14 日（星期三）开市起撤销其他风险警示，股 票简称由"ST 易事特"变更为"易事特"，证券代码仍为"300376"，撤销其 他风险警示后，公司股票交易的日涨跌幅限制不变，仍为 20%。 关于公司股票交易撤销其他风险警示暨 停牌一天的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、股票种类、简称、证券代码、涨跌幅、撤销其他风险警示的起始日及 股票停复牌起始日 易事特集团股份有限公司 特别提示： 1、易事特集团股份有限公司（以下简称"公司"）股票交易将于 2026 年 1 月 13 日（星期二）停牌一天，并于 2026 年 1 月 14 日（星期三）开市起复牌。 1、股票种类：人民币普通股 A 股 2、股票简称："ST 易事特"变更为"易事特" 5、公司股票停复牌起始日：公司股票将于 2026 年 1 月 13 日停牌一天，2026 年 1 月 14 日开市起复牌。 6、撤销其他风险警示后，公司股票交易的日涨跌幅限制不变，仍为 20%。 二 ...

Core Viewpoint - The company ST Yishite will remove the other risk warning from its stock starting January 14, 2026, and the stock name will change from "ST Yishite" to "Yishite" while the security code remains "300376" [1] Summary by Categories - Stock Trading Status - The company's stock will be suspended for one day on January 13, 2026, and will resume trading on January 14, 2026 [1] - Risk Warning Removal - The removal of the other risk warning will not change the daily price fluctuation limit for the company's stock, which remains at 20% [1]